Similar articles

• Routine heparin for patients with cancer? One answer, more questions.

  Akl EA, Schünemann HJ. Akl EA, et al. N Engl J Med. 2012 Feb 16;366(7):661-2. doi: 10.1056/NEJMe1113672. N Engl J Med. 2012. PMID: 22335745 No abstract available.
• Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

  Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators. Agnelli G, et al. N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898. N Engl J Med. 2012. PMID: 22335737 Clinical Trial.
• Semuloparin helps prevent thromboembolic events in patients receiving chemotherapy.

  [No authors listed] [No authors listed] Oncology (Williston Park). 2012 Mar;26(3):258, 264. Oncology (Williston Park). 2012. PMID: 22545309 No abstract available.
• Semuloparin for the prevention of venous thromboembolic events in cancer patients.

  Gras J. Gras J. Drugs Today (Barc). 2012 Jul;48(7):451-7. doi: 10.1358/dot.2012.48.7.1838374. Drugs Today (Barc). 2012. PMID: 22844656 Review.
• Treatment of venous thrombosis.

  Lee AY. Lee AY. Cancer Treat Res. 2009;148:243-57. doi: 10.1007/978-0-387-79962-9_14. Cancer Treat Res. 2009. PMID: 19377928 Review. No abstract available.